Long-read metagenomics market seen topping $4.69 billion by 2030

The long-read metagenomics market is projected to nearly triple from 2025 to 2030 as demand grows for infectious disease diagnostics, pathogen surveillance and precision medicine. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Long-read metagenomics is becoming a more important tool for identifying pathogens, antimicrobial resistance genes and microbial communities in complex samples. - The market’s growth reflects rising demand for faster diagnostics and surveillance as infectious diseases spread and drug-resistant threats increase. - The technology is also gaining relevance in precision medicine, clinical metagenomics and public health monitoring.

What happened: - The Business Research Company published its Long-Read Metagenomics Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market is projected to rise from $1.79 billion in 2025 to $2.16 billion in 2026. - The report forecasts the market will reach $4.69 billion by 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available. - The full market report is also available.

The details: - The market’s recent expansion has been driven by lower DNA sequencing costs, broader use of next-generation sequencing platforms, more microbiome research, higher funding for genomic programs and new metagenomic assembly tools. - The forecast period through 2030 assumes a 21.3% compound annual growth rate. - Long-read metagenomics uses sequencing technologies that produce extended DNA reads from biological or environmental samples. - The approach supports more complete genome assembly, clearer genetic relationship analysis and better characterization of microbial communities. - The report says wider adoption of precision medicine, clinical metagenomics diagnostics, real-time pathogen monitoring, AI-powered genomic analytics and portable sequencing devices will support future growth. - Anticipated trends include better microbial strain resolution, improved error correction and assembly polishing, environmental DNA-based pathogen surveillance, ultra-deep profiling for rare species and improved sample preparation for high molecular weight DNA extraction. - The World Health Organization reported in October 2024 that about 8.2 million new tuberculosis cases were diagnosed globally in 2023, up from 7.5 million in 2022.

Between the lines: - The forecast suggests long-read metagenomics is moving from a specialized research tool toward broader clinical and surveillance use. - Faster growth in Asia-Pacific points to a widening global market beyond established research hubs. - The emphasis on AI, portability and real-time monitoring signals competition around speed, field deployment and data interpretation, not just sequencing accuracy.

What’s next: - Market growth will likely track adoption in infectious disease diagnostics, outbreak response and precision medicine programs. - Product development should center on better sample prep, improved assembly software and tools that make long-read data easier to use in clinical settings. - The report’s added 2026 features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspots infographics.

The bottom line: - Long-read metagenomics is shifting into a higher-growth phase as healthcare, research and public health buyers look for deeper, faster and more actionable genomic analysis.